Table 5.
OS | Survival probability (%) | ||||||
---|---|---|---|---|---|---|---|
<2 cycles (n = 216) | ≥2 cycles (n = 15) | <15 days (n = 226) | ≥15 days (n = 5) | ≥85 % RDI (n = 226) | <85 % RDI (n = 5) | Overall % (95 % CI) | |
2 years | 99 | 93 | 99 | 100 | 99 | 100 | 99 (97–100) |
p | 0.061 | 0.796 | 0.796 | ||||
4 years | 98 | 93 | 97 | 100 | 98 | 80 | 97 (95–99) |
p | 0.302 | 0.712 | 0.014* | ||||
5 years | 97 | 93 | 97 | 100 | 97 | 80 | 97 (95–99) |
p | 0.395 | 0.687 | 0.026* | ||||
6 years | 93 | 93 | 93 | 100 | 93 | 80 | 93 (89–97) |
p | 0.849 | 0.539 | 0.135 | ||||
8 years | 92 | 93 | 92 | 100 | 92 | 80 | 92 (87–96) |
p | 0.902 | 0.514 | 0.165 | ||||
10 years | 81 | 93 | 81 | 100 | 82 | 80 | 82 (72–92) |
p | 0.888 | 0.418 | 0.245 |
CI confidence interval, RDI relative dose intensity, OS overall survival
* Statistically significant